Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 310 entries
Sorted by: Best Match Show Resources per page
Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial

interventions

[No authors listed]
GSID: LlSDU_XMULQJ
H Von Hertzen, G Piaggio, A Peregoudov, J Ding… - The Lancet, 2002 - Elsevier

Background A single 10 mg dose of mifepristone, and two 0· 75 mg doses of levonorgestrel 12 h apart, are effective for emergency contraception. Because no studies had compared the …

Voluntary termination of pregnancy (medical or surgical abortion): forensic medicine issues.

Open medicine (Warsaw, Poland)

Piras M, Delbon P, Bin P, Casella C, Capasso E, Niola M, Conti A.
PMID: 28352815
Open Med (Wars). 2016 Aug 13;11(1):321-326. doi: 10.1515/med-2016-0062. eCollection 2016.

In Italy, Law 194 of 22 May 1978 provides for and regulates the voluntary termination of pregnancy (VTP). Medical abortion became popular nationwide after Mifepristone (RU-486) was authorized for the market by AIFA (Italian Drug Agency) in July 2009....

Cite
Piras M, Delbon P, Bin P, et al. Voluntary termination of pregnancy (medical or surgical abortion): forensic medicine issues. Open Med (Wars). 2016;11(1):321-326doi: 10.1515/med-2016-0062.
Piras, M., Delbon, P., Bin, P., Casella, C., Capasso, E., Niola, M., & Conti, A. (2016). Voluntary termination of pregnancy (medical or surgical abortion): forensic medicine issues. Open medicine (Warsaw, Poland), 11(1), 321-326. https://doi.org/10.1515/med-2016-0062
Piras, Mauro, et al. "Voluntary termination of pregnancy (medical or surgical abortion): forensic medicine issues." Open medicine (Warsaw, Poland) vol. 11,1 (2016): 321-326. doi: https://doi.org/10.1515/med-2016-0062
Piras M, Delbon P, Bin P, Casella C, Capasso E, Niola M, Conti A. Voluntary termination of pregnancy (medical or surgical abortion): forensic medicine issues. Open Med (Wars). 2016 Aug 13;11(1):321-326. doi: 10.1515/med-2016-0062. eCollection 2016. PMID: 28352815; PMCID: PMC5329849.
Copy Download .nbib Format: NLM
Enablers of and barriers to abortion training.

Journal of graduate medical education

Guiahi M, Lim S, Westover C, Gold M, Westhoff CL.
PMID: 24404266
J Grad Med Educ. 2013 Jun;5(2):238-43. doi: 10.4300/JGME-D-12-00067.1.

BACKGROUND: Since the legalization of abortion services in the United States, provision of abortions has remained a controversial issue of high political interest. Routine abortion training is not offered at all obstetrics and gynecology (Ob-Gyn) training programs, despite a...

Cite
Guiahi M, Lim S, Westover C, et al. Enablers of and barriers to abortion training. J Grad Med Educ. 2013;5(2):238-43doi: 10.4300/JGME-D-12-00067.1.
Guiahi, M., Lim, S., Westover, C., Gold, M., & Westhoff, C. L. (2013). Enablers of and barriers to abortion training. Journal of graduate medical education, 5(2), 238-43. https://doi.org/10.4300/JGME-D-12-00067.1
Guiahi, Maryam, et al. "Enablers of and barriers to abortion training." Journal of graduate medical education vol. 5,2 (2013): 238-43. doi: https://doi.org/10.4300/JGME-D-12-00067.1
Guiahi M, Lim S, Westover C, Gold M, Westhoff CL. Enablers of and barriers to abortion training. J Grad Med Educ. 2013 Jun;5(2):238-43. doi: 10.4300/JGME-D-12-00067.1. PMID: 24404266; PMCID: PMC3693687.
Copy Download .nbib Format: NLM
Low-Dose Mifepristone Versus Placebo to Treat Uterine Myoma: A Double-Blind, Randomized Clinical Trial.

Journal of minimally invasive gynecology

Liu C.
PMID: 27679378
J Minim Invasive Gynecol. 2015 Nov-Dec;22(6):S91. doi: 10.1016/j.jmig.2015.08.245. Epub 2015 Oct 15.

No abstract available.

Cite
Liu C. Low-Dose Mifepristone Versus Placebo to Treat Uterine Myoma: A Double-Blind, Randomized Clinical Trial. J Minim Invasive Gynecol. 2015;22(6):S91doi: 10.1016/j.jmig.2015.08.245.
Liu, C. (2015). Low-Dose Mifepristone Versus Placebo to Treat Uterine Myoma: A Double-Blind, Randomized Clinical Trial. Journal of minimally invasive gynecology, 22(6), S91. https://doi.org/10.1016/j.jmig.2015.08.245
Liu, C. "Low-Dose Mifepristone Versus Placebo to Treat Uterine Myoma: A Double-Blind, Randomized Clinical Trial." Journal of minimally invasive gynecology vol. 22,6 (2015): S91. doi: https://doi.org/10.1016/j.jmig.2015.08.245
Liu C. Low-Dose Mifepristone Versus Placebo to Treat Uterine Myoma: A Double-Blind, Randomized Clinical Trial. J Minim Invasive Gynecol. 2015 Nov-Dec;22(6):S91. doi: 10.1016/j.jmig.2015.08.245. Epub 2015 Oct 15. PMID: 27679378.
Copy Download .nbib Format: NLM
A Retrospective Case-Control Study Evaluating the Role of Mifepristone for Induction of Labor in Women with Previous Cesarean Section.

Journal of obstetrics and gynaecology of India

Sharma C, Soni A, Soni PK, Verma S, Verma A, Gupta A.
PMID: 27651574
J Obstet Gynaecol India. 2016 Oct;66:30-7. doi: 10.1007/s13224-015-0760-3. Epub 2015 Sep 01.

OBJECTIVE: To investigate the role of "mifepristone" for induction of labor (IOL) in pregnant women with prior cesarean section (CS).METHODS: In this retrospective study, all pregnant women with prior CS who received oral mifepristone (400 mg) for IOL (as...

Cite
Sharma C, Soni A, Soni PK, et al. A Retrospective Case-Control Study Evaluating the Role of Mifepristone for Induction of Labor in Women with Previous Cesarean Section. J Obstet Gynaecol India. 2015;66:30-7doi: 10.1007/s13224-015-0760-3.
Sharma, C., Soni, A., Soni, P. K., Verma, S., Verma, A., & Gupta, A. (2016). A Retrospective Case-Control Study Evaluating the Role of Mifepristone for Induction of Labor in Women with Previous Cesarean Section. Journal of obstetrics and gynaecology of India, 6630-7. https://doi.org/10.1007/s13224-015-0760-3
Sharma, Chanderdeep, et al. "A Retrospective Case-Control Study Evaluating the Role of Mifepristone for Induction of Labor in Women with Previous Cesarean Section." Journal of obstetrics and gynaecology of India vol. 66 (2016): 30-7. doi: https://doi.org/10.1007/s13224-015-0760-3
Sharma C, Soni A, Soni PK, Verma S, Verma A, Gupta A. A Retrospective Case-Control Study Evaluating the Role of Mifepristone for Induction of Labor in Women with Previous Cesarean Section. J Obstet Gynaecol India. 2016 Oct;66:30-7. doi: 10.1007/s13224-015-0760-3. Epub 2015 Sep 01. PMID: 27651574; PMCID: PMC5016401.
Copy Download .nbib Format: NLM
Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome.

Case reports in endocrinology

Moraitis AG, Auchus RJ.
PMID: 26989527
Case Rep Endocrinol. 2016;2016:8453801. doi: 10.1155/2016/8453801. Epub 2016 Feb 17.

A 30-year-old Caucasian man presented with severe Cushing's syndrome (CS) resulting from ectopic adrenocorticotropin syndrome (EAS) from a metastatic pancreatic neuroendocrine tumor. The patient remained hypercortisolemic despite treatment with steroidogenesis inhibitors, chemotherapy, and octreotide long-acting release (LAR) and was...

Cite
Moraitis AG, Auchus RJ. Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome. Case Rep Endocrinol. 2016;2016:8453801doi: 10.1155/2016/8453801.
Moraitis, A. G., & Auchus, R. J. (2016). Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome. Case reports in endocrinology, 20168453801. https://doi.org/10.1155/2016/8453801
Moraitis, Andreas G, and Auchus, Richard J. "Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome." Case reports in endocrinology vol. 2016 (2016): 8453801. doi: https://doi.org/10.1155/2016/8453801
Moraitis AG, Auchus RJ. Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome. Case Rep Endocrinol. 2016;2016:8453801. doi: 10.1155/2016/8453801. Epub 2016 Feb 17. PMID: 26989527; PMCID: PMC4773543.
Copy Download .nbib Format: NLM
Mifepristone was more effective than the Yuzpe regimen for emergency contraception.

Evidence-based nursing

Satove L.
PMID: 12546032
Evid Based Nurs. 2003 Jan;6(1):14. doi: 10.1136/ebn.6.1.14.

No abstract available.

Cite
Satove L. Mifepristone was more effective than the Yuzpe regimen for emergency contraception. Evid Based Nurs. 2003;6(1):14doi: 10.1136/ebn.6.1.14.
Satove, L. (2003). Mifepristone was more effective than the Yuzpe regimen for emergency contraception. Evidence-based nursing, 6(1), 14. https://doi.org/10.1136/ebn.6.1.14
Satove, Laurel. "Mifepristone was more effective than the Yuzpe regimen for emergency contraception." Evidence-based nursing vol. 6,1 (2003): 14. doi: https://doi.org/10.1136/ebn.6.1.14
Satove L. Mifepristone was more effective than the Yuzpe regimen for emergency contraception. Evid Based Nurs. 2003 Jan;6(1):14. doi: 10.1136/ebn.6.1.14. PMID: 12546032.
Copy Download .nbib Format: NLM
Meningiomas.

Current treatment options in neurology

Chamberlain MC.
PMID: 11123860
Curr Treat Options Neurol. 2001 Jan;3(1):67-76. doi: 10.1007/s11940-001-0025-6.

Meningiomas are extra-axial brain tumors of middle-to-late adult life and show a predominance in women. Overall, 90% of meningiomas are benign, 6% atypical, and 2% are malignant. Most patients diagnosed with a meningioma decide to have it removed surgically,...

Cite
Chamberlain MC. Meningiomas. Curr Treat Options Neurol. 2001;3(1):67-76doi: 10.1007/s11940-001-0025-6.
Chamberlain, M. C. (2001). Meningiomas. Current treatment options in neurology, 3(1), 67-76. https://doi.org/10.1007/s11940-001-0025-6
Chamberlain. "Meningiomas." Current treatment options in neurology vol. 3,1 (2001): 67-76. doi: https://doi.org/10.1007/s11940-001-0025-6
Chamberlain MC. Meningiomas. Curr Treat Options Neurol. 2001 Jan;3(1):67-76. doi: 10.1007/s11940-001-0025-6. PMID: 11123860.
Copy Download .nbib Format: NLM
Intracerebral Meningiomas.

Current treatment options in neurology

Chamberlain MC.
PMID: 15157407
Curr Treat Options Neurol. 2004 Jul;6(4):297-305. doi: 10.1007/s11940-004-0029-0.

Meningiomas are extra-axial brain tumors of middle to late adult life, and they have a female predominance. Overall, 90% of meningiomas are benign, 6% are atypical, and 2% are malignant. Most patients diagnosed with a meningioma decide to have...

Cite
Chamberlain MC. Intracerebral Meningiomas. Curr Treat Options Neurol. 2004;6(4):297-305doi: 10.1007/s11940-004-0029-0.
Chamberlain, M. C. (2004). Intracerebral Meningiomas. Current treatment options in neurology, 6(4), 297-305. https://doi.org/10.1007/s11940-004-0029-0
Chamberlain, Marc C.. "Intracerebral Meningiomas." Current treatment options in neurology vol. 6,4 (2004): 297-305. doi: https://doi.org/10.1007/s11940-004-0029-0
Chamberlain MC. Intracerebral Meningiomas. Curr Treat Options Neurol. 2004 Jul;6(4):297-305. doi: 10.1007/s11940-004-0029-0. PMID: 15157407.
Copy Download .nbib Format: NLM
Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms.

Mediators of inflammation

Zamir O, Hasselgren PO, Higashiguchi T, Frederick JA, Fischer JE.
PMID: 18475468
Mediators Inflamm. 1992;1(4):247-50. doi: 10.1155/S0962935192000371.

The purpose of this study was to test the hypothesis that muscle proteolysis induced by TNF or IL-1 is mediated by glucocorticoids. Rats were treated with 300 mug kg(-1) of recombinant human preparations of IL-1alpha (rIL-1alpha) or TNFalpha (rTNFalpha)...

Cite
Zamir O, Hasselgren PO, Higashiguchi T, et al. Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediators Inflamm. 1992;1(4):247-50doi: 10.1155/S0962935192000371.
Zamir, O., Hasselgren, P. O., Higashiguchi, T., Frederick, J. A., & Fischer, J. E. (1992). Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediators of inflammation, 1(4), 247-50. https://doi.org/10.1155/S0962935192000371
Zamir, O, et al. "Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms." Mediators of inflammation vol. 1,4 (1992): 247-50. doi: https://doi.org/10.1155/S0962935192000371
Zamir O, Hasselgren PO, Higashiguchi T, Frederick JA, Fischer JE. Tumour necrosis factor (TNF) and interleukin-1 (IL-1) induce muscle proteolysis through different mechanisms. Mediators Inflamm. 1992;1(4):247-50. doi: 10.1155/S0962935192000371. PMID: 18475468; PMCID: PMC2365344.
Copy Download .nbib Format: NLM
Oxidized lipoproteins suppress nitric oxide synthase in macrophages: study of glucocorticoid receptor involvement.

Mediators of inflammation

Matthys KE, Jorens PG, Marescau B, Rosseneu M, Bult H, Herman AG.
PMID: 18475575
Mediators Inflamm. 1994;3(5):323-7. doi: 10.1155/S096293519400044X.

Activated cholesterol-laden macrophages in atherosclerotic lesions are believed to influence the progression of this disease. The induction of nitric oxide synthase (iNOS) activity was investigated in control and cholesterol-laden J774 macrophages, obtained by pre-incubation with oxidized or acetylated low...

Cite
Matthys KE, Jorens PG, Marescau B, et al. Oxidized lipoproteins suppress nitric oxide synthase in macrophages: study of glucocorticoid receptor involvement. Mediators Inflamm. 1994;3(5):323-7doi: 10.1155/S096293519400044X.
Matthys, K. E., Jorens, P. G., Marescau, B., Rosseneu, M., Bult, H., & Herman, A. G. (1994). Oxidized lipoproteins suppress nitric oxide synthase in macrophages: study of glucocorticoid receptor involvement. Mediators of inflammation, 3(5), 323-7. https://doi.org/10.1155/S096293519400044X
Matthys, K E, et al. "Oxidized lipoproteins suppress nitric oxide synthase in macrophages: study of glucocorticoid receptor involvement." Mediators of inflammation vol. 3,5 (1994): 323-7. doi: https://doi.org/10.1155/S096293519400044X
Matthys KE, Jorens PG, Marescau B, Rosseneu M, Bult H, Herman AG. Oxidized lipoproteins suppress nitric oxide synthase in macrophages: study of glucocorticoid receptor involvement. Mediators Inflamm. 1994;3(5):323-7. doi: 10.1155/S096293519400044X. PMID: 18475575; PMCID: PMC2365568.
Copy Download .nbib Format: NLM
Use of mifepristone in second trimester termination of pregnancy in a patient with anomalous reproductive tract anatomy.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Lyall H, Mahmood TA.
PMID: 15511792
J Obstet Gynaecol. 1997 Jan;17(1):108-9. doi: 10.1080/01443619750114365.

No abstract available.

Cite
Lyall H, Mahmood TA. Use of mifepristone in second trimester termination of pregnancy in a patient with anomalous reproductive tract anatomy. J Obstet Gynaecol. 1997;17(1):108-9doi: 10.1080/01443619750114365.
Lyall, H., & Mahmood, T. A. (1997). Use of mifepristone in second trimester termination of pregnancy in a patient with anomalous reproductive tract anatomy. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 17(1), 108-9. https://doi.org/10.1080/01443619750114365
Lyall, H, and Mahmood, T A. "Use of mifepristone in second trimester termination of pregnancy in a patient with anomalous reproductive tract anatomy." Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology vol. 17,1 (1997): 108-9. doi: https://doi.org/10.1080/01443619750114365
Lyall H, Mahmood TA. Use of mifepristone in second trimester termination of pregnancy in a patient with anomalous reproductive tract anatomy. J Obstet Gynaecol. 1997 Jan;17(1):108-9. doi: 10.1080/01443619750114365. PMID: 15511792.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 310 entries